Vittoria Biotherapeutics

Vittoria Biotherapeutics

Private
Philadelphia, PennsylvaniaHealthcare & Life Scienceshttps://vittoriabio.com

Last Round

Private Financing

Extension

Nov 12, 2024

Total Funding Raised

$10M

Company Overview

Vittoria Biotherapeutics is a biotechnology company developing novel CAR T-cell therapies that transcend the limitations of current cell therapies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

CAR T-cell therapycell therapyimmunotherapyT-cell lymphomacell and gene therapyCGTSenza5 platformcell therapy manufacturinggene editingautologous cell therapysolid tumorsautoimmune diseasesclinical-stage biotechCD5 signaling

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Vittoria Biotherapeutics Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Vittoria Biotherapeutics Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Private Financing ExtensionNov 12, 2024
VC RoundNov 14, 2023
SeedJun 7, 2022

Key People

Founding team and executive leadership

Nicholas Siciliano

Chief Executive Officer

Executive Team

Keith Westby

Chief Operating Officer

Executive Team

Vittoria Biotherapeutics Investors

Notable investors and investment history

InvestorRounds
Agent CapitalPrivate Financing Extension, Seed, VC Round
University of PennsylvaniaPrivate Financing Extension, VC Round
Tellus BioVenturesPrivate Financing Extension, Seed, VC Round
Valley Forge Investment CorporationPrivate Financing Extension, VC Round
BioAdvance CapitalVC Round
Global BioAccess FundPrivate Financing Extension
Hatch BiofundPrivate Financing Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 3, 2025

    Attended the 10th annual Penn Center for Innovation's Celebration of Innovation.

  • Dec 3, 2025

    Recognized for advancements in cellular therapy for T-cell lymphoma.

Vittoria Biotherapeutics Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Vittoria Biotherapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Vittoria Biotherapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersPhiladelphia, Pennsylvania
Employee Range12
Year Founded2021
Last FundingNov 12, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.